Koninklijke Philips | PHG - Des Atouts





Des Atouts Changement Date
Abbott USD 86.71B 2.53B 2025-12
Baxter International USD 20.06B 1.01B 2025-12
Becton, Dickinson and Co. USD 54.84B 484M 2025-12
Boston Scientific USD 43.67B 966M 2025-12
Danaher USD 83.46B 3.57B 2025-12
Demant DKK 39.07B 6.43B 2025-12
Dexcom USD 6.34B 1.16B 2025-12
Edwards Lifesciences USD 13.27B 216.5M 2025-09
Fresenius EUR 42.46B 1.14B 2025-09
General Electric Aerospace USD 130.17B 1.93B 2025-12
Getinge SEK 63.92B 4.3B 2024-12
Globus Medical USD 5.3B 207.12M 2025-12
GN Store Nord DKK 29.23B 170M 2025-12
Hitachi JPY 14.68T 797.57B 2025-12
Idexx Laboratories USD 3.35B 35.95M 2025-12
Insulet USD 3.19B 161.1M 2025-12
Integra LifeSciences USD 3.6B 44.45M 2025-12
Intuitive Surgical USD 20.46B 1.11B 2025-12
J&J USD 199.21B 6.39B 2025-12
Koninklijke Philips EUR 31.65B 742.15M 2025-12
Masimo USD 1.7B 118.6M 2025-12
Medtronic USD 91.48B 139M 2025-12
Philips EUR 26.94B 605M 2025-12
ResMed USD 8.5B 195.02M 2025-12
Smith & Nephew USD 10.69B 150M 2025-12
Steris USD 10.59B 180.7M 2025-12
Stryker USD 47.84B 787M 2025-12
Teleflex USD 6.95B 924.7M 2025-12
Terumo JPY 2.26T 362.12B 2025-12
Zimmer Biomet Holdings USD 23.09B 396.3M 2025-12